Cargando…
Adenosine‐Induced Coronary Steal Is Observed in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction
BACKGROUND: Adenosine is used to treat no‐reflow in the infarct‐related artery (IRA) during ST‐segment–elevation myocardial infarction intervention. However, the physiological effect of adenosine in the IRA is variable. Coronary steal—a reduction of blood flow to the distal coronary bed—can occur in...
Autores principales: | Aetesam‐ur‐Rahman, Muhammad, Brown, Adam J., Jaworski, Catherine, Giblett, Joel P., Zhao, Tian X., Braganza, Denise M., Clarke, Sarah C., Agrawal, Bobby S. K., Bennett, Martin R., West, Nick E. J., Hoole, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403291/ https://www.ncbi.nlm.nih.gov/pubmed/34187187 http://dx.doi.org/10.1161/JAHA.120.019899 |
Ejemplares similares
-
GLP-1 vasodilatation in humans with coronary artery disease is not adenosine mediated
por: Aetesam-ur-Rahman, Muhammad, et al.
Publicado: (2021) -
Glucagon-Like Peptide-1–Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion
por: Giblett, Joel P., et al.
Publicado: (2019) -
Coronary Flow Variations Following Percutaneous Coronary Intervention Affect Diastolic Nonhyperemic Pressure Ratios More Than the Whole Cycle Ratios
por: Aetesam‐ur‐Rahman, Muhammad, et al.
Publicado: (2022) -
Rituximab in patients with acute ST-elevation myocardial infarction: an experimental medicine safety study
por: Zhao, Tian X, et al.
Publicado: (2021) -
GLP‐1 Is a Coronary Artery Vasodilator in Humans
por: Clarke, Sophie J., et al.
Publicado: (2018)